Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Dexbrompheniramine maleate; pseudoephedrine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dexbrompheniramine maleate; pseudoephedrine sulfate and what is the scope of patent protection?

Dexbrompheniramine maleate; pseudoephedrine sulfate
is the generic ingredient in six branded drugs marketed by Copley Pharm, Pioneer Pharms, Avanthi Inc, Sandoz, Schering Plough, and Schering, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for dexbrompheniramine maleate; pseudoephedrine sulfate.

Summary for Generic Name: dexbrompheniramine maleate; pseudoephedrine sulfate

Drug Master File Entries: see list7
Clinical Trials: see list358
Drug Prices:see low prices
DailyMed Link:dexbrompheniramine maleate; pseudoephedrine sulfate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copley Pharm
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL089116-001Jan 22, 1987DISCNNoNo► Subscribe► Subscribe
Schering Plough
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL013483-003Sep 13, 1982DISCNYesNo► Subscribe► Subscribe
Schering Plough
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL013483-004Sep 13, 1982DISCNNoNo► Subscribe► Subscribe
Pioneer Pharms
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL089139-001Jun 16, 1988DISCNNoNo► Subscribe► Subscribe
dexbrompheniramine maleate; pseudoephedrine sulfate
TABLET;ORAL012394-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus